Sphere Fluidics, a Cambridge University life sciences spin-out, has secured the first tranche of a £2m ($3.4m) funding round. The initial sum, which remains undisclosed, comes via Parkwalk Advisors through the Cambridge University Enterprise Fund II and Parkwalk Fund IV.
Cambridge University previously invested in Sphere Fluidics in February 2013 through its Enterprise Fund I, as part of the company’s series A of £1.6m ($2.5m). The series A was led by 24Haymarket and also included the Royal Society.
Sphere Fluidics…
